newsfilter
← Latest News
GlobeNewswire·

Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023

Announcing addition of two new TCRs to the library, estimated to double the addressable market; plans to further expand TCR library using hunTR® TCR discovery platformIncreasing patient enrollment to advance TCR-T